RSMDF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Resmed Inc

Watchlist Manager

Watchlist

Price: 16.72 USD

Market Cap: $24.7B

	Resmed Inc OTC:RSMDF	US
	Innate Pharma SA PAR:IPH	FR
	Hong Leong Finance Ltd SGX:S41	SG
	DS Smith PLC OTC:DSSMY	UK
	Cricut Inc F:398	US
	Christian Dior SE F:DIO0	FR
D	Dexcom Inc XMUN:DC4	US
L	Lamar Advertising Co F:6LA	US
N	Nintendo Co Ltd XBER:NTO	JP
	Monopar Therapeutics Inc F:1IY0	US

Profitability Summary

Resmed Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

62%

Strong 3Y Average Gross Margin

58%

Gross Margin is Increasing

56% > 62%

Exceptional Operating Margin

35%

Strong 3Y Average Operating Margin

31%

Operating Margin is Increasing

27% > 35%

Healthy Net Margin

27%

Sustainable 3Y Average Net Margin

24%

Net Margin is Increasing

21% > 27%

Exceptional Free Cash Flow Margin

31%

Strong 3Y Average Free Cash Flow Margin

27%

Free Cash Flow Margin is Increasing

13% > 31%

Exceptional ROE

25%

Positive 3Y Average ROE

Positive 3Y Average ROIC

19%

ROIC is Increasing

17% > 23%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.